These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24334258)

  • 1. Modulating Wnt signaling to improve cell replacement therapy for Parkinson's disease.
    Parish CL; Thompson LH
    J Mol Cell Biol; 2014 Feb; 6(1):54-63. PubMed ID: 24334258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.
    Arenas E
    J Mol Cell Biol; 2014 Feb; 6(1):42-53. PubMed ID: 24431302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of cell therapies and brain repair: Parkinson's disease leads the way.
    Petit GH; Olsson TT; Brundin P
    Neuropathol Appl Neurobiol; 2014 Feb; 40(1):60-70. PubMed ID: 24372386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in stem-cell--generated transplantation therapy for Parkinson's disease.
    Sundberg M; Isacson O
    Expert Opin Biol Ther; 2014 Apr; 14(4):437-53. PubMed ID: 24437368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluripotent stem cells as new drugs? The example of Parkinson's disease.
    Preynat-Seauve O; Burkhard PR; Villard J; Zingg W; Ginovart N; Feki A; Dubois-Dauphin M; Hurst SA; Mauron A; Jaconi M; Krause KH
    Int J Pharm; 2009 Nov; 381(2):113-21. PubMed ID: 19782880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell transplantation and gene therapy in Parkinson's disease.
    Wakeman DR; Dodiya HB; Kordower JH
    Mt Sinai J Med; 2011; 78(1):126-58. PubMed ID: 21259269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell replacement therapy for Parkinson's disease: how close are we to the clinic?
    Ganz J; Lev N; Melamed E; Offen D
    Expert Rev Neurother; 2011 Sep; 11(9):1325-39. PubMed ID: 21864078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice.
    Bye CR; Thompson LH; Parish CL
    Exp Neurol; 2012 Jul; 236(1):58-68. PubMed ID: 22524988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral function of bone marrow multipotent adult progenitor cells after transplantation in Parkinson's disease rat models.
    Zhang N; Zhou H; Wang H; Yu L; Li Z; Xu H; Wang M
    Transplant Proc; 2013 Mar; 45(2):719-25. PubMed ID: 23498812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.
    Harrower TP; Tyers P; Hooks Y; Barker RA
    Exp Neurol; 2006 Jan; 197(1):56-69. PubMed ID: 16246328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.